Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Age-dependent impairment of eyeblink conditioning in prion protein-deficient mice.

Kishimoto Y, Hirono M, Atarashi R, Sakaguchi S, Yoshioka T, Katamine S, Kirino Y.

PLoS One. 2013 Apr 10;8(4):e60627. doi: 10.1371/journal.pone.0060627. Print 2013.

2.

Mother-to-child transmission of human T-cell lymphotropic virus type 1.

Moriuchi H, Masuzaki H, Doi H, Katamine S.

Pediatr Infect Dis J. 2013 Feb;32(2):175-7. doi: 10.1097/INF.0b013e31827efc39. Review. No abstract available.

PMID:
23328821
3.

Biological and biochemical characterization of mice expressing prion protein devoid of the octapeptide repeat region after infection with prions.

Yamaguchi Y, Miyata H, Uchiyama K, Ootsuyama A, Inubushi S, Mori T, Muramatsu N, Katamine S, Sakaguchi S.

PLoS One. 2012;7(8):e43540. doi: 10.1371/journal.pone.0043540. Epub 2012 Aug 21.

4.

Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein.

Kubota T, Hamazoe Y, Hashiguchi S, Ishibashi D, Akasaka K, Nishida N, Katamine S, Sakaguchi S, Kuroki R, Nakashima T, Sugimura K.

J Biol Chem. 2012 Apr 20;287(17):14023-39. doi: 10.1074/jbc.M111.318352. Epub 2012 Feb 22.

5.

Orally administered prion protein is incorporated by m cells and spreads into lymphoid tissues with macrophages in prion protein knockout mice.

Takakura I, Miyazawa K, Kanaya T, Itani W, Watanabe K, Ohwada S, Watanabe H, Hondo T, Rose MT, Mori T, Sakaguchi S, Nishida N, Katamine S, Yamaguchi T, Aso H.

Am J Pathol. 2011 Sep;179(3):1301-9. doi: 10.1016/j.ajpath.2011.05.058. Epub 2011 Jul 18.

6.

Transcytosis of murine-adapted bovine spongiform encephalopathy agents in an in vitro bovine M cell model.

Miyazawa K, Kanaya T, Takakura I, Tanaka S, Hondo T, Watanabe H, Rose MT, Kitazawa H, Yamaguchi T, Katamine S, Nishida N, Aso H.

J Virol. 2010 Dec;84(23):12285-91. doi: 10.1128/JVI.00969-10. Epub 2010 Sep 22.

7.

Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis.

Khan KN, Kitajima M, Hiraki K, Yamaguchi N, Katamine S, Matsuyama T, Nakashima M, Fujishita A, Ishimaru T, Masuzaki H.

Fertil Steril. 2010 Dec;94(7):2860-3.e1-3. doi: 10.1016/j.fertnstert.2010.04.053.

PMID:
20627244
8.

Human papillomavirus DNA in plasma of patients with HPV16 DNA-positive uterine cervical cancer.

Shimada T, Yamaguchi N, Nishida N, Yamasaki K, Miura K, Katamine S, Masuzaki H.

Jpn J Clin Oncol. 2010 May;40(5):420-4. doi: 10.1093/jjco/hyp193. Epub 2010 Feb 4.

PMID:
20133337
9.

Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique.

Fujihara A, Atarashi R, Fuse T, Ubagai K, Nakagaki T, Yamaguchi N, Ishibashi D, Katamine S, Nishida N.

FEBS J. 2009 May;276(10):2841-8. doi: 10.1111/j.1742-4658.2009.07007.x.

10.

Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice.

Yoshikawa D, Yamaguchi N, Ishibashi D, Yamanaka H, Okimura N, Yamaguchi Y, Mori T, Miyata H, Shigematsu K, Katamine S, Sakaguchi S.

J Biol Chem. 2008 Aug 29;283(35):24202-11. doi: 10.1074/jbc.M804212200. Epub 2008 Jun 18.

11.

Hot spots in prion protein for pathogenic conversion.

Kuwata K, Nishida N, Matsumoto T, Kamatari YO, Hosokawa-Muto J, Kodama K, Nakamura HK, Kimura K, Kawasaki M, Takakura Y, Shirabe S, Takata J, Kataoka Y, Katamine S.

Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11921-6. Epub 2007 Jul 6.

12.

Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region.

Mori T, Moriuchi R, Okazaki E, Yamada K, Katamine S.

Biochem Biophys Res Commun. 2007 Apr 20;355(4):937-43. Epub 2007 Feb 20.

PMID:
17328864
13.

Tgat, a Rho-specific guanine nucleotide exchange factor, activates NF-kappaB via physical association with IkappaB kinase complexes.

Yamada K, Moriuchi R, Mori T, Okazaki E, Kohno T, Nagayasu T, Matsuyama T, Katamine S.

Biochem Biophys Res Commun. 2007 Mar 30;355(1):269-74. Epub 2007 Feb 2.

PMID:
17292329
14.

Immunohistochemical characterization of cell types expressing the cellular prion protein in the small intestine of cattle and mice.

Miyazawa K, Kanaya T, Tanaka S, Takakura I, Watanabe K, Ohwada S, Kitazawa H, Rose MT, Sakaguchi S, Katamine S, Yamaguchi T, Aso H.

Histochem Cell Biol. 2007 Mar;127(3):291-301. Epub 2006 Dec 13.

PMID:
17165097
15.

Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion.

Ishibashi D, Yamanaka H, Yamaguchi N, Yoshikawa D, Nakamura R, Okimura N, Yamaguchi Y, Shigematsu K, Katamine S, Sakaguchi S.

Vaccine. 2007 Jan 22;25(6):985-92. Epub 2006 Oct 6.

PMID:
17055125
16.
17.

Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.

Atarashi R, Sim VL, Nishida N, Caughey B, Katamine S.

J Virol. 2006 Aug;80(16):7854-62.

18.

14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.

Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata M, Niwa M, Katamine S, Kurihara S, Matsuo H.

Cell Mol Neurobiol. 2006 Feb;26(1):45-52.

PMID:
16633900
19.

Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin.

Yamanaka H, Ishibashi D, Yamaguchi N, Yoshikawa D, Nakamura R, Okimura N, Arakawa T, Tsuji T, Katamine S, Sakaguchi S.

Vaccine. 2006 Apr 5;24(15):2815-23. Epub 2006 Jan 17.

PMID:
16446015
20.

Identification of NADH dehydrogenase 1 alpha subcomplex 5 capable to transform murine fibroblasts and overexpressed in human cervical carcinoma cell lines.

Shimada T, Moriuchi R, Mori T, Yamada K, Ishimaru T, Katamine S.

Biochem Biophys Res Commun. 2006 Jan 20;339(3):852-7. Epub 2005 Nov 28.

PMID:
16329995
21.

Reciprocal interference between specific CJD and scrapie agents in neural cell cultures.

Nishida N, Katamine S, Manuelidis L.

Science. 2005 Oct 21;310(5747):493-6.

22.

Female-specific neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion protein-like protein.

Sakurai-Yamashita Y, Sakaguchi S, Yoshikawa D, Okimura N, Masuda Y, Katamine S, Niwa M.

Neuroscience. 2005;136(1):281-7. Epub 2005 Sep 28.

PMID:
16198494
23.

Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.

Arima K, Nishida N, Sakaguchi S, Shigematsu K, Atarashi R, Yamaguchi N, Yoshikawa D, Yoon J, Watanabe K, Kobayashi N, Mouillet-Richard S, Lehmann S, Katamine S.

J Virol. 2005 Jun;79(11):7104-12.

24.

Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease.

Satoh K, Shirabe S, Eguchi K, Yamauchi A, Kataoka Y, Niwa M, Nishida N, Katamine S.

Cell Mol Neurobiol. 2004 Dec;24(6):873-5.

PMID:
15672687
25.

Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

Nishiura Y, Nakamura T, Fukushima N, Moriuchi R, Katamine S, Eguchi K.

Tohoku J Exp Med. 2004 Dec;204(4):289-98.

26.

An alternative transcript derived from the trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential.

Yoshizuka N, Moriuchi R, Mori T, Yamada K, Hasegawa S, Maeda T, Shimada T, Yamada Y, Kamihira S, Tomonaga M, Katamine S.

J Biol Chem. 2004 Oct 15;279(42):43998-4004. Epub 2004 Aug 11.

27.

Doppel-induced Purkinje cell death is stoichiometrically abrogated by prion protein.

Yamaguchi N, Sakaguchi S, Shigematsu K, Okimura N, Katamine S.

Biochem Biophys Res Commun. 2004 Jul 9;319(4):1247-52.

PMID:
15194501
28.

Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier.

Dohgu S, Yamauchi A, Takata F, Sawada Y, Higuchi S, Naito M, Tsuruo T, Shirabe S, Niwa M, Katamine S, Kataoka Y.

Cell Mol Neurobiol. 2004 Apr;24(2):205-17.

PMID:
15176436
29.

A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine. Contamination with bacterial outer membrane proteins.

Furukawa H, Doh-ura K, Okuwaki R, Shirabe S, Yamamoto K, Udono H, Ito T, Katamine S, Niwa M.

J Biol Chem. 2004 May 28;279(22):23661-7. Epub 2004 Mar 18.

30.

[Iatrogenic Creutzfeldt-Jakob disease].

Satoh K, Shirabe S, Katamine S, Muramoto T, Kitamoto T.

Nihon Rinsho. 2004 Jan;62 Suppl:248-51. Review. Japanese. No abstract available.

PMID:
15011359
31.

Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study.

Arisawa K, Sobue T, Yoshimi I, Soda M, Shirahama S, Doi H, Katamine S, Saito H, Urata M.

Cancer Causes Control. 2003 Nov;14(9):889-96.

PMID:
14682446
32.

EAAT4 mRNA expression is preserved in the cerebellum of prion protein-deficient mice.

Yukitake M, Satoh J, Katamine S, Kuroda Y.

Neurosci Lett. 2003 Dec 11;352(3):171-4.

PMID:
14625012
33.

Cellular prion protein promotes Brucella infection into macrophages.

Watarai M, Kim S, Erdenebaatar J, Makino S, Horiuchi M, Shirahata T, Sakaguchi S, Katamine S.

J Exp Med. 2003 Jul 7;198(1):5-17.

34.

Inactivation of porcine endogenous retrovirus by human serum as a function of complement activated through the classical pathway.

Fujita F, Yamashita-Futsuki I, Eguchi S, Kamohara Y, Fujioka H, Yanaga K, Furui J, Moriuchi R, Kanematsu T, Katamine S.

Hepatol Res. 2003 Jun;26(2):106-113.

PMID:
12809937
35.

Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration.

Atarashi R, Nishida N, Shigematsu K, Goto S, Kondo T, Sakaguchi S, Katamine S.

J Biol Chem. 2003 Aug 1;278(31):28944-9. Epub 2003 May 19.

36.

Allogeneic cell stimulation enhances cytomegalovirus replication in the early period of primary infection in an experimental rat model.

Tamura K, Oka T, Ohsawa K, Koji T, Watanabe Y, Katamine S, Sato H, Ayabe H.

J Heart Lung Transplant. 2003 Apr;22(4):452-9.

PMID:
12681423
37.

[Infectious protein, "prion"--from the discovery of Kuru to the emergence of a new variant of Creutzfeldt-Jakob disease].

Nakamura T, Katamine S.

Nihon Naika Gakkai Zasshi. 2002 Oct 10;91(10):2864-7. Review. Japanese. No abstract available.

PMID:
12451636
38.

A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.

Arisaw K, Katamine S, Kamihira S, Kurokawa K, Sawada T, Soda M, Doi H, Saito H, Shirahama S.

Cancer Causes Control. 2002 Sep;13(7):657-63.

PMID:
12296513
39.

Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dpl.

Atarashi R, Sakaguchi S, Shigematsu K, Arima K, Okimura N, Yamaguchi N, Li A, Kopacek J, Katamine S.

Mol Med. 2001 Dec;7(12):803-9.

40.

Apoptosis in neural crest cells by functional loss of APC tumor suppressor gene.

Hasegawa S, Sato T, Akazawa H, Okada H, Maeno A, Ito M, Sugitani Y, Shibata H, Miyazaki Ji J, Katsuki M, Yamauchi Y, Yamamura Ki K, Katamine S, Noda T.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):297-302. Epub 2001 Dec 26.

41.

HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Okazaki S, Moriuchi R, Yosizuka N, Sugahara K, Maeda T, Jinnai I, Tomonaga M, Kamihira S, Katamine S.

Virus Genes. 2001;23(2):123-35.

PMID:
11724264
42.

PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C).

Deli MA, Sakaguchi S, Nakaoke R, Abrahám CS, Takahata H, Kopacek J, Shigematsu K, Katamine S, Niwa M.

Neuroreport. 2000 Nov 27;11(17):3931-6.

PMID:
11117517
43.

Pentosan polysulfate regulates scavenger receptor-mediated, but not fluid-phase, endocytosis in immortalized cerebral endothelial cells.

Deli MA, Abrahám CS, Takahata H, Katamine S, Niwa M.

Cell Mol Neurobiol. 2000 Dec;20(6):731-45.

PMID:
11100980
44.

Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.

Nakaoke R, Sakaguchi S, Atarashi R, Nishida N, Arima K, Shigematsu K, Katamine S.

Cell Mol Neurobiol. 2000 Dec;20(6):717-30.

PMID:
11100979
45.

Prion infection impairs the cellular response to oxidative stress.

Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mangé A, Arlotto M, Casanova D, Riondel J, Favier A, Lehmann S.

Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13937-42.

46.

Identification of genes associated with the progression of adult T cell leukemia (ATL).

Kohno T, Moriuchi R, Katamine S, Yamada Y, Tomonaga M, Matsuyama T.

Jpn J Cancer Res. 2000 Nov;91(11):1103-10.

47.

Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP-deficient mice ataxic due to Purkinje cell degeneration.

Li A, Sakaguchi S, Shigematsu K, Atarashi R, Roy BC, Nakaoke R, Arima K, Okimura N, Kopacek J, Katamine S.

Am J Pathol. 2000 Nov;157(5):1447-52.

48.

Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins.

Nakane S, Shirabe S, Moriuchi R, Mizokami A, Furuya T, Nishiura Y, Okazaki S, Yoshizuka N, Suzuki Y, Nakamura T, Katamine S, Gojobori T, Eguchi K.

J Neurovirol. 2000 Aug;6(4):275-83.

PMID:
10951551
49.

[Physiopathology and molecular diagnosis for prion diseases].

Katamine S.

Rinsho Byori. 2000 May;48(5):437-41. Review. Japanese.

PMID:
10892292
50.

Gene expression profile in prion protein-deficient fibroblasts in culture.

Satoh J, Kuroda Y, Katamine S.

Am J Pathol. 2000 Jul;157(1):59-68.

Supplemental Content

Loading ...
Support Center